Abstract
One problem that has long frustrated cancer chemotherapy is the inability to predict which patients with tumors of the same histopathologic type and stage will respond and which will be resistant to identical treatment. The human tumor colony assay is an important new tool that promises to aid both development of anticancer drugs and clinical use of chemotherapy.